XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Cash flow from operating activities:          
Net loss $ 47,826 $ (64,477) $ (15,041) $ (146,016) $ (100,118)
Adjustments to reconcile net loss to net cash used in operations:          
Depreciation and amortization     4,603 3,867  
Non cash lease expense     (25)    
Deferred income taxes       (1,356)  
Provision for doubtful accounts     3 115  
Change in fair value of warrant liabilities (43,212) 1,174 (22,280) 37,679  
Stock-based compensation expense     6,951 29,197  
Change in fair value of contingent consideration     (40,198) 30,704  
Change in fair value of contingent stock consideration     611    
Other, net     (212) 3,049  
Changes in assets and liabilities:          
Accounts receivable     (1,191) 90  
Inventory     (14,692) (1,688)  
Prepaid expenses and other assets     511 (1,851)  
Sale of net operating loss and R&D tax credits       1,356  
Accounts payable     1,020 1,636  
Accrued expenses and other liabilities     9,079 1,226  
Right-of-use assets and lease liabilities     128    
Deferred revenue     162 (1,288)  
Net cash used in operating activities     (70,571) (43,280)  
Cash flow from investing activities:          
Capital expenditures     (2,894) (2,787)  
Proceeds from promissory note       300  
Net cash used in investing activities     (2,894) (2,487)  
Cash flow from financing activities:          
Proceeds from short term borrowings - related party       5,000  
Proceeds from the exercise of stock options     248 14  
Proceeds from the exercise of warrants     46,489    
Proceeds from PIPE financing     30,000    
Payments of PIPE/SPAC related costs     (2,523) (5,841)  
Net cash provided by (used in) financing activities     74,214 (827)  
Net increase (decrease) in cash, cash equivalents and restricted cash     749 (46,594)  
Cash, cash equivalents and restricted cash at beginning of period     52,076 69,513 69,513
Cash, cash equivalents and restricted cash at end of period $ 52,825 $ 22,919 52,825 22,919 $ 52,076
Supplemental disclosure of cash flow information:          
Cash paid for income taxes       11  
Supplemental non-cash investing and financing activities:          
Property and equipment included in accounts payable and accrued expenses     (953) (252)  
PIPE related costs included in accrued expenses     (81)    
Reclassification of option liabilities to equity     $ 441    
Change in PIPE/SPAC related costs captured in accounts payable and accrued expenses       $ 1,526